体外膜肺氧合支持时长与心血管外科患者生存的关系
该单中心注册研究纳入354例心血管外科术后接受静脉-动脉体外膜肺氧合(ECMO)支持的成人患者,中位随访45个月,245例(69%)死亡。ECMO支持时间延长与死亡率增加相关,ECMO存活者中第三与第二三分位时长相比2年死亡率粗HR为1.96,多变量校正后HR为2.30。作者建议重新评估ECMO支持7天后的治疗策略。
要点
- ECMO支持时间延长与心血管外科术后患者死亡率增加相关。
- ECMO存活者中,较长ECMO时长与2年死亡率粗HR 1.96(95%CI 1.40-2.74;P<.001)相关。
- 多变量校正后HR为2.30(95%CI 1.52-3.48;P<.001),作者建议重新评估ECMO支持7天后的策略。
核心结论
- 延长静脉-动脉ECMO支持与心血管外科术后成人患者的不良结局相关。
- 作者的数据提示应重新评估ECMO支持7天后的治疗策略,因为此后死亡率不成比例地增加。
研究设计与样本
- 单中心注册研究,纳入354例在大学附属三级医疗中心心血管外科术后接受静脉-动脉ECMO支持的成人患者。
主要发现
- 中位随访45个月(四分位距20-81个月)期间,245例(69%)死亡。
- ECMO支持时间延长与死亡率增加相关。
- ECMO存活者中,ECMO时长第三与第二三分位相比,2年死亡率粗HR为1.96(95%CI 1.40-2.74;P<.001)。
- 使用bootstrap选择的混杂因素模型多变量校正后,2年长期死亡率校正HR为2.30(95%CI 1.52-3.48;P<.001)。
临床怎么用
- 作者认为,ECMO支持7天后死亡率不成比例增加,提示应重新评估治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The overall therapeutic goal of venoarterial extracorporeal membrane oxygenation (ECMO) in patients with postcardiotomy shock is bridging to myocardial recovery. However, in patients with irreversible myocardial damage prolonged ECMO treatment would cause a delay or even withholding of further permanent potentially life-saving therapeutic options. We therefore assessed the prognostic effect of duration of ECMO support on survival in adult patients after cardiovascular surgery. METHODS: We enrolled into our single-center registry a total of 354 patients who underwent venoarterial ECMO support after cardiovascular surgery at a university-affiliated tertiary care center. RESULTS: Through a median follow-up period of 45 months (interquartile range, 20-81 months), 245 patients (69%) died. We observed an increase in mortality with increasing duration of ECMO support. The association between increased duration of ECMO support and mortality persisted in patients who survived ECMO support with a crude hazard ratio of 1.96 (95% confidence interval, 1.40-2.74; P < .001) for 2-year mortality compared with the third tertile and the second tertile of ECMO duration. This effect was even more pronounced after multivariate adjustment using a bootstrap-selected confounder model with an adjusted hazard ratio of 2.30 (95% confidence interval, 1.52-3.48; P < .001) for 2-year long-term mortality. CONCLUSIONS: Prolonged venoarterial ECMO support is associated with poor outcome in adult patients after cardiovascular surgery. Our data suggest reevaluation of therapeutic strategies after 7 days of ECMO support because mortality disproportionally increases afterward.
引用
- Distelmaier K, Wiedemann D, Binder C, et al. Duration of extracorporeal membrane oxygenation support and survival in cardiovascular surgery patients. J Thorac Cardiovasc Surg. 2017. PMID: 29395201. doi:10.1016/j.jtcvs.2017.12.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。